Rockville, MD, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Based on a new research report published by Fact.MR, the global orally disintegrating tablet market is poised to reach a valuation of US$ 24.45 billion ...

Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Orally Disintegrating Tablet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, ...

The authors demonstrated that ODTs can be obtained by direct compression of a mixture of starch, fructose, and SMCC. An estimated 35% of the general population suffers from dysphagia (i.e., difficulty ...

Orally disintegrating tablets offer numerous advantages compared with traditional tablets and capsules, and can be an effective solution for developing line extensions of currently marketed therapies.

It will grow to $22.53 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%.” - The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, August 23, 2025 /EINPresswire / -- "Get ...

Offering a simple set-up specifically for vaginal tablets, the new tester reduces equipment investment costs relative to those associated with generic suppository testing, while at the same time ...

Please provide your email address to receive an email when new articles are posted on . APT-1011, a novel fluticasone orally disintegrating tablet, effectively induced histologic response, improved ...

The US Food and Drug Administration (FDA) has approved an amphetamine extended-release orally disintegrating tablet (Adzenys XR-ODT) for the treatment of attention ...